Pulse Biosciences Incの時価総額
Pulse Biosciences Incの時価総額は何ですか。
Pulse Biosciences Incの時価総額は107.59M$です。
時価総額の定義は何ですか。
時価総額は、取引された会社の発行済株式の市場価値であり、一定期間のb株式に発行済株式数を掛けたものに等しい。
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
NASDAQのセクタHealth Careにおける時価総額の企業と比べるPulse Biosciences Inc
Pulse Biosciences Incは何をしますか。
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Pulse Biosciences Incと類似の時価総額
- Nova Royaltyの時価総額は107.36M$です。
- Fronsac Real Estate Investment Trustの時価総額は107.48M$です。
- Creades ABの時価総額は107.54M$です。
- Volpara Health Technologiesの時価総額は107.55M$です。
- Baring Emerging Europe Plcの時価総額は107.57M$です。
- Intergroupの時価総額は107.59M$です。
- Pulse Biosciences Incの時価総額は107.59M$です。
- Mind Gym plcの時価総額は107.61M$です。
- HKEの時価総額は107.62M$です。
- Pioneer Floating Rate Fund Incの時価総額は107.62M$です。
- Bardoc Goldの時価総額は107.64M$です。
- Alio Goldの時価総額は107.66M$です。
- Southeast Asia Properties & Financeの時価総額は107.69M$です。